Concepedia

Jianheng Bao

JB

Statistics

Publications

3

Citations

42

H-Index

3

Active since

2015

Affiliations

Tianjin Nankai Hospital(Current)

Jianheng Bao is an author at Tianjin Nankai Hospital specializing in molecular oncology, pharmacology, and cancer pharmacology.

Publications per year

2015–2021

3

Publications

3

CSN5 silencing reverses sorafenib resistance of human hepatocellular carcinoma HepG2 cells

Haibo Wang, Zhengyao Qian, Hui Zhao et al. · Molecular Medicine Reports · 2015 · 18 citations · Full text

Medicine, Oncology, Pharmacology +16

Sugiol (127horbar;hydroxyabieta-8,11,13-trien-7-one) targets human pancreatic carcinoma cells (Mia-PaCa2) by inducing apoptosis, G2/M cell cycle arrest, ROS production and inhibition of cancer cell migration.

Chengfei Hao, Xibo Zhang, Hongtao Zhang et al. · PubMed · 2019 · 14 citations

Medicine, Oncology, Pharmacology +17

The choice of operation timing of laparoscopic cholecystectomy (LC) after percutaneous transhepatic gallbladder drainage (PTGBD) for acute cholecystitis: a retrospective clinical analysis

Jianheng Bao, Jianxiong Wang, Hai-Tao Shang et al. · Annals of Palliative Medicine · 2021 · 10 citations · Full text

Medicine, Surgery, Gastroenterology +15

1–3 of 3